Cardiovascular and Metabolic Sciences Biorepository

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06560424

Enrollment

10000

Registered

2024-08-19

Start date

2024-09-18

Completion date

2050-12-31

Last updated

2026-06-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Diseases, Metabolic Disease

Keywords

Biorepository

Brief summary

The purpose of the Cardiovascular and Metabolic Sciences Biorepository is to collect and store information and biospecimens (blood, urine, stool, and heart tissue) from patients with and without cardiovascular and metabolic diseases to create a readily available biorepository of samples and related medical health information to expedite future research into the causes and consequences of cardiovascular and metabolic diseases.

Detailed description

Heart disease is the leading cause of death in the United States and other vascular diseases, like stroke, and metabolic diseases, like diabetes, are consistently in the top ten causes of death (CDC, 2024). There is clearly a need for continuing research and innovation into improved diagnosis and treatment of these diseases. The goal of this biorepository is to provide an easily accessible collection of samples for researchers to utilize. The biorepository will also serve as a place to store residual samples from other cardiovascular disease (CVD) studies for future use, to make the best use of these biospecimen resources.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

OTHER

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Willing and able to sign the informed consent document

Exclusion criteria

* Chronic anemia (hemoglobin consistently \<9 g/L)

Design outcomes

Primary

Measure	Time frame	Description
Number of samples enrolled per year	Yearly through study completion (approximately 30 years)	Establish a biorepository of samples (blood, urine, stool, and heart tissue) and related medical health information to support future investigation into cardiovascular and metabolic diseases.

Countries

United States

Contacts

CONTACTJennifer Wilcox, BA

kirsopj@ccf.org216-636-6153

CONTACTValesha Province, MA

provinv@ccf.org216-636-6153

PRINCIPAL_INVESTIGATORW. H. Wilson Tang, MD

The Cleveland Clinic

Outcome results